3-month triptorelin in premenopausal patients with hormone receptor-positive early breast cancer: a commentary and a retrospective experience.
Caruso, Michele
3-month triptorelin in premenopausal patients with hormone receptor-positive early breast cancer: a commentary and a retrospective experience. [electronic resource] - Future oncology (London, England) 2015 - 3109-12 p. digital
Publication Type: Letter
1744-8301
10.2217/fon.15.261 doi
Antineoplastic Agents, Hormonal--therapeutic use
Breast Neoplasms--drug therapy
Chemotherapy, Adjuvant
Female
Gonadotropin-Releasing Hormone--agonists
Humans
Neoplasm Staging
Premenopause
Receptors, Estrogen--metabolism
Receptors, Progesterone
Treatment Outcome
Triptorelin Pamoate--therapeutic use
3-month triptorelin in premenopausal patients with hormone receptor-positive early breast cancer: a commentary and a retrospective experience. [electronic resource] - Future oncology (London, England) 2015 - 3109-12 p. digital
Publication Type: Letter
1744-8301
10.2217/fon.15.261 doi
Antineoplastic Agents, Hormonal--therapeutic use
Breast Neoplasms--drug therapy
Chemotherapy, Adjuvant
Female
Gonadotropin-Releasing Hormone--agonists
Humans
Neoplasm Staging
Premenopause
Receptors, Estrogen--metabolism
Receptors, Progesterone
Treatment Outcome
Triptorelin Pamoate--therapeutic use